GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,468.50p
   
  • Change Today:
    -20.00p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,293.50
  • Currency: UK Pounds
  • Shares Issued: 4,129.58m
  • Volume: 1,345,272
  • Market Cap: £60,643m
  • RiskGrade: 129
  • Beta: 0.01

Latest ShareCast News

EMA accepts GSK's application to expand Nucala use

By Josh White

Date: Monday 24 Mar 2025

(Sharecast News) - GSK said on Monday that the European Medicines Agency has accepted its application to expand the use of 'Nucala', or mepolizumab, to include patients with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype.

FDA to review GSK's depemokimab

By Iain Gilbert

Date: Monday 03 Mar 2025

(Sharecast News) - Pharmaceutical giant GSK said on Monday that the US Food and Drug Administration has agreed to review its Biologics License Application for the use of its depemokimab asset in two indications.

London close: Stocks little changed after UK data dump

By Josh White

Date: Friday 21 Feb 2025

(Sharecast News) - London stocks closed with little direction on Friday as investors weighed fresh economic data, including signs of slowing private sector growth.

GSK seen as potential target for activist invest... 21-Feb-2025 ShareCast
London close: Stocks slip as US jobless claims r... 20-Feb-2025 ShareCast
GSK 5-in1 meningitis drug gets US approval 17-Feb-2025 ShareCast
GSK ups five-year sales outlook, unveils $2bn bu... 05-Feb-2025 ShareCast
GSK's pre-filled shingles vaccine accepted for r... 27-Jan-2025 ShareCast
EU regulators expand usage of GSK's Jemperli can... 20-Jan-2025 ShareCast
Pfizer pares back Haleon stake in £2.5bn sale 15-Jan-2025 ShareCast
London close: Stocks fall, pound weakens further... 13-Jan-2025 ShareCast
GSK to buy IDRx for up to $1.15bn 13-Jan-2025 ShareCast
GSK application for new Shingrix formulation acc... 10-Jan-2025 ShareCast
GSK cancer drug candidate gets another breakthro... 07-Jan-2025 ShareCast
London close: Stocks finish first week of 2025 w... 03-Jan-2025 ShareCast
GSK's Nucala gets third approval in China 03-Jan-2025 ShareCast
GSK reports positive results from ovarian cancer... 20-Dec-2024 ShareCast
EU recommends expanding use of GSK endometrial c... 16-Dec-2024 ShareCast
GSK says US agrees to look at data for new use o... 09-Dec-2024 ShareCast
GSK extends strategic vaccine collaboration with... 05-Dec-2024 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,468.50p
Change Today -20.00p
% Change -1.34 %
52 Week High 1,812.50
52 Week Low 1,293.50
Volume 1,345,272
Shares Issued 4,129.58m
Market Cap £60,643m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Price Trend
2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income
62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 31-Mar-2025

Time Volume / Share Price
12:09 71 @ 1,468.50p
12:09 21 @ 1,468.50p
12:09 1,795 @ 1,468.50p
12:09 868 @ 1,468.67p
12:08 498 @ 1,469.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page